Alessa Therapeutics, Inc. — Form D
Alessa Therapeutics, Inc. of SAN CARLOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-26. The offering totals $3.5M, of which $3.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-03-26
- Form: D
- Accession: 0001771653-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.0M
- Remaining: $500K
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2019-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-335630
Issuer
- Name: Alessa Therapeutics, Inc.
- CIK: 0001771653
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 930 BRITTAN AVENUE, SAN CARLOS, CA, 94070
- Phone: 650-223-5912
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Richard Lim | Director | BOSTON, MA |
| Annie Mitsak | Director | Boston, MA |
| Cam Gallagher | Director | San Diego, CA |
| Cam Gallagher | Executive Officer | San Diego, CA |
| Zachary Collins | Executive Officer | Holland, MI |
| Steve Tregay | Director | San Carlos, CA |
| Douglas Crawford | Director | San Francisco, CA |
| Pamela Munster | Director | San Carlos, CA |
| Peter Parker | Director | Boston, MA |
| John Maroney | Director | San Francisco, CA |
| John Maroney | Executive Officer | San Francisco, CA |
| Doug Crawford | Director | San Francisco, CA |
Other filings by this issuer (2)
More